51.5
Gyre Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
49.7
FY23:
57.2
FY24:
64.8
FY25:
102
(positive)
Change from FY21 to FY25
millions USD
FY21:
4.19
FY22:
35.1
FY23:
59.3
FY24:
60.6
FY25:
63.8
Total assets
Change from FY21 to FY25
millions USD
FY21:
55.7
FY22:
84.8
FY23:
117
FY24:
125
FY25:
166
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
14.2
FY22:
12.2
FY23:
20.0
FY24:
19.5
FY25:
18.3
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.41
FY22:
0.29
FY23:
18.0
FY24:
7.49
FY25:
5.56
(positive)
Change from FY21 to FY25
millions USD
FY21:
41.1
FY22:
42.5
FY23:
−15.8
FY24:
63.3
FY25:
106
Total liabilities & equity
millions USD
FY21:
55.7
FY22:
–
FY23:
–
FY24:
–
FY25:
–
All amounts in millions USD